Janux Therapeutics Inc (JANX)
NASDAQ
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.33 | 9.6824686941 | 44.72 | 51.63 | 43.35 | 708639 | 47.55155607 | CS |
4 | 4.48 | 10.0516042181 | 44.57 | 51.63 | 41.23 | 471622 | 45.5782406 | CS |
12 | 7.86 | 19.0823015295 | 41.19 | 51.63 | 34.5125 | 528855 | 42.50459365 | CS |
26 | 9.24 | 23.2102486812 | 39.81 | 65.6 | 34.5125 | 690491 | 46.11347588 | CS |
52 | 39.12 | 393.957703927 | 9.93 | 65.6 | 5.65 | 537725 | 42.60884887 | CS |
156 | 22.07 | 81.8013343217 | 26.98 | 65.6 | 5.65 | 242286 | 35.47000287 | CS |
260 | 15.05 | 44.2647058824 | 34 | 65.6 | 5.65 | 245239 | 34.67959629 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.